Relationship between Microvascular Density and Expression of Vascular Endothelial Growth Factor in Patients with Ovarian Endometriosis
Ovarian endometriosis patients with pain symptoms showed higher microvascular density, but no difference in vascular endothelial growth factor expression, compared to asymptomatic patients.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (31)
- Angiogenesis in Endometriosis via openalex
- Angiogenic Factors in Endometriosis via openalex
- Antiangiogenesis Therapy for Endometriosis via openalex
- Endometriosis and pelvic pain: epidemiological evidence of the relationship and implications via openalex
- Endometriosis: What a Pain It Is via openalex
- High concentrations of the vascular endothelial growth factor and interleukin-8 in ovarian endometriomata via openalex
- Image analysis measurements of the microvascularisation in endometrium, superficial and deep endometriotic tissues via openalex
- Immunohistochemical analysis of vascular endothelial growth factor cellular expression in ovarian endometriomata via openalex
- Immunohistochemical localization of acidic and basic fibroblast growth factors in normal human endometrium and endometriosis and the detection of their mRNA by polymerase chain reaction via openalex
- Increased vascular surface density in ovarian endometriosis via openalex
- Levels of vascular endothelial growth factor (VEGF) in serum of patients with endometriosis via openalex
- Ovarian endometrioma vascularization in women with pelvic pain via openalex
- Peritoneal endometriosis, ovarian endometriosis, and adenomyotic nodules of the rectovaginal septum are three different entities via openalex
- Relationship between stage, site and morphological characteristics of pelvic endometriosis and pain via openalex
- Revised American Society for Reproductive Medicine classification of endometriosis: 1996 via openalex
- The follicular and endocrine environment in women with endometriosis: local and systemic cytokine production via openalex
- The relationship between microvessel density, proliferative activity and expression of vascular endothelial growth factor-A and its receptors in eutopic endometrium and endometriotic lesions via openalex
- Transvaginal colour Doppler in patients with ovarian endometriomas and pelvic pain via openalex
- Vascular development in endometriosis via openalex
- Vascular endothelial growth factor (VEGF) and ovarian endometriosis: correlation between VEGF serum levels, VEGF cellular expression, and pelvic pain via openalex
- W2020968632 via openalex
- W2291960606 via openalex
- W4247664461 via openalex
- W2059612167 via openalex
- W2063058031 via openalex
- W1994143652 via openalex
- W1985959551 via openalex
- W1985712533 via openalex
- W2140246703 via openalex
- W2160882660 via openalex
- W2211028096 via openalex
Cited by (9)
- Targeting NGF but not VEGF or BDNF signaling reduces endometriosis-associated pain in mice 2023
- The Role of the Microenvironment in Endometriosis: Parallels and Distinctions to Cancer 2022
- Proteomics Research and Its Possibility of Application in Endometriosis 2019
- Endometriosis — insights into a multifaceted entity 2018
- Chronic Pelvic Pain in Endometriosis: An Overview 2013
- Serum biomarker profiles of interleukin-6, tumor necrosis factor alpha, matrix-metalloproteinase-2, and vascular endothelial growth factor in endometriosis staging 2013
- The Epigenetics of Endometriosis 2012
- Histone deacetylase inhibitors as therapeutics for endometriosis 2012
- Promoter Hypermethylation of Progesterone Receptor Isoform B (PR-B) in Adenomyosis and Its Rectification by a Histone Deacetylase Inhibitor and a Demethylation Agent 2010
Source provenance
- europepmc
- last seen: 2026-06-04T01:30:01.192114+00:00
- openalex
- last seen: 2026-06-04T00:00:01.174412+00:00
- pubmed
- last seen: 2026-05-13T22:14:36.758325+00:00